The human stories behind Bristol scientists who are playing an important role in global efforts to overcome COVID-19 have been captured in a billboard campaign by a Bristol-based photographer.
A new discovery by University of Bristol scientists helps to explain how cells which surround blood vessels, called pericytes, stimulate new blood vessels to grow with the hormone ‘leptin’ playing a key role. Leptin is produced by fat cells which helps to regulate energy balance in the body by inhibiting the appetite. This study, described in Scientific Reports, may have important implications for the treatment of heart attacks and also for cancer, the two main killers in the UK.
The University of Bristol held its first Animal Welfare and Research 3Rs symposium last month [Thursday 27 April]. During the symposium, scientists had the opportunity to find out about current research and share best practice of the ‘3Rs’: Replace, Reduce and Refine.
New research led by the University of Bristol, has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer’s disease (AD) in people with mild-to-moderate disease after 12 months of treatment. However, the drug could still be of benefit if prescribed for longer and if given to people with very early disease. The findings are from the phase 2 multi-centre clinical trial known as RADAR ((Reducing pathology in Alzheimer’s Disease through Angiotensin taRgeting).
People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found. The study, led by the University of Bristol and published in GeroScience, analysed, for the first time, ten population cohort studies with over one million participants.
A ‘living bandage’ made from stem cells, which could revolutionise the treatment and prognosis of a common sporting knee injury, has been trialled in humans for the first time by scientists at the Universities of Liverpool and Bristol.
A new simple blood test for brain tumours that could be used by GPs in primary care will be developed thanks to funding of nearly £500,000 by Cancer Research UK. Around 60,000 patients in the UK are living with a brain tumour but only 20 per cent of patients are still alive five years after diagnosis, partly because they present late with large inoperable tumours.
Frontline healthcare workers say they are angry at being treated as 'COVID cannon fodder, not COVID heroes' after responding to the virus for nearly two years and working at full capacity, reveal the findings of new research.
More than 2.6 million stillbirths continue to occur globally every year with very slow progress made to tackle this ‘silent problem’, according to new research published in The Lancet.
Aspirin can reduce the risk of serious cardiovascular events such as ischemic stroke and heart attack in patients with pneumonia, according to new research.
